Premature Ovarian Failure
Research from Royal Hospital for Sick Children Provides New Data about Premature Ovarian Failure
Published in Women's Health Weekly, February 3rd, 2011
2011 FEB 3 -- According to a study from Scotland, "The aim of this exploratory study was to establish whether we could improve skeletal health with a physiological regimen of SSR in young women with premature ovarian failure (POF). In an open-label randomized controlled crossover trial, 34 women with POF were randomized to 4-week cycles of pSSR (transdermal oestradiol, 100 mu g daily for week 1, 150 mu g for weeks 2-4; vaginal progesterone, 200 mg twice daily for weeks 3-4) or standard hormone replacement treatment (sHRT) (oral ethinyloestradiol 30 mu g and 1 center dot 5 mg norethisterone daily for weeks 1-3, week 4 'pill-free') for 12 months."
"Bone...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Osteoporosis
Columbia University uses technological innovation to study bone structure - Endometrial Cancer
Data from University of Texas Advance Knowledge in Endometrial Cancer - Breast Cancer
Data on Breast Cancer Described by Researchers at Case Western Reserve University - Breast Cancer
Data on Breast Cancer Discussed by Researchers at Oita University, Medical Department - Obstetrics
Data on Obstetrics Described by Researchers at Royal Marsden Hospital, Department of Radiology - Ovarian Cancer
Data on Ovarian Cancer Discussed by Researchers at Ain Shams University - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
